¿Influye el tipo de anticoagulante en la incidencia de infección asociada al catéter venoso central en hemodiálisis?
Does the kind of anticoagulant influence the incidence of central venous catheter associated infection on hemodialysis?
Resumen
Bibliografía
1. Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, et al. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis [Internet]. 2014;63(3):479–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24125729
2. Moher D, Liberati A, Tetzlaff J, Altman DG & the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med [Internet]. 2009;151(4):264-69. doi:10.7326/0003-4819-151-4-200908180-00135
3. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Method [Internet]. 2007;7(10):1-7.
4. Weijmer MC, van den Dorpel MA, van de Ven PJG, ter Wee PM, van Geelen JACA, Groeneveld JO, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol [Internet]. 2005;16(9):2769–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16033861
5. Baltrons Bosch A, Coll Vinyoles S, Font Senen C, Jubany López M, Plana Illa C, Sunyer García A. Estudio comparativo del sellado de catéteres con citrato trisódico o heparina sódica más gentamicina. Rev la Soc Española Enfermería Nefrológica [Internet]. Sociedad Española de Enfermería Nefrológica; 2007;11(2):19–24. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-13752008000200004&lng=es&nrm=iso&tlng=es
6. Bevilacqua JL, Gomes JG, Santos VFB, Canziani MEF. Comparação entre citrato trissódico e heparina como solução para selo de cateter em pacientes em hemodiálise. J Bras Nefrol [Internet]. Sociedade Brasileira de Nefrologia; 2011;33(1):86–92. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002011000100012&lng=en&nrm=iso&tlng=pt
7. Fincias Pérez M, Rollán de la Sota MJ, Marcos Álamo M, Gandía Fernández A. Estudio del uso del citrato para el sellado de catéteres en hemodiálisis. Rev la Soc Española Enfermería Nefrológica [Internet]. Sociedad Española de Enfermería Nefrológica; 2008;11(4):319–22. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-13752008000400008&lng=es&nrm=iso&tlng=es
8. Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant [Internet]. 2010;25(6):1753–6. Available from: http://ndt.oxfordjournals.org/content/early/2010/04/19/ndt.gfq205.1.full
9. Boersma RS, Jie KS, Voogd AC, Hamulyak K, Verbon A, Schouten HC. Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignancies. Support Care Cancer [Internet]. 2015;23(1):37–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24947057
10. Yon CK, Low CL. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters. Am J Heal Pharm [Internet]. 2013;70(2):131–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23292266
11. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis [Internet]. 2009;53(6):1034–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19394731
12. Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, et al. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purif [Internet]. 2010;29(3):268–73. Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-73649114226&partnerID=tZOtx3y1
13. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters - an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant [Internet]. 2007;22(2):471–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17065193
14. Lamela Rivas L, Muriel Ríos E, Illanes Suárez S, Hussein Cobos S, Abeijón Carreño T, Ornosa Agra C. Sellado de catéteres en hemodiálisis. Estudio piloto comparativo de dos soluciones de sellado: heparina sódica al 1% versus citrato sódico al 4% (Citraflow®). Rev la Soc Española Enfermería Nefrológica [Internet]. Sociedad Española de Enfermería Nefrológica; 2014;17(1):139. Available from:
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254-28842014000500107&lng=es&nrm=iso&tlng=es
15. Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, et al. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol [Internet]. 2014;9(7):1232–9. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4078967&tool=pmcentrez&rendertype=abstract
16. Hadaway L. Heparin Locking for Central Venous Catheters. J Assoc Vasc Access [Internet]. 2006;11(4):224–31. Available from: http://www.sciencedirect.com/science/article/pii/S1552885506701799
17. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis [Internet]. 2008;51(2):233–41. Available from:
http://www.sciencedirect.com/science/article/pii/S0272638607014898
18. Moran JE, Ash SR. Locking solutions for hemodialysis catheters: heparin and citrate - a position paper by ASDIN. Semin Dial [Internet]. 2008;21(5):490–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764795
19. Conway MA, McCollom C, Bannon C. Central Venous Catheter Flushing Recommendations: A Systematic Evidence-Based Practice Review. J Pediatr Oncol Nurs [Internet]. 2014;31(4):185–90. Available from:
http://0-web.b.ebscohost.com.llull.uib.es/ehost/detail/detail?vid=10&sid=b3d557c1-089a-4cb6-ab51-4a3637ef24a4%40sessionmgr198&hid=101&bdata=Jmxhbmc9ZXMmc2l0ZT1laG9zdC1saXZl#AN=103961748&db=c8h
20. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs [Internet]. 2009;65(10):2007–21. Available from:
http://www.scopus.com/inward/record.url?eid=2-s2.0-70349093989&partnerID=tZOtx3y1
21. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RMA. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant [Internet]. 2007;22(2):477–83. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17018541
22. Encarnação R, Marques P. Permeabilidade do cateter venoso central: uma revisão sistemática da literatura. Rev Enferm Ref [Internet]. 2013;3(9):161–9. Available from:
http://www.researchgate.net/publication/268799929_Permeabilidade_do_cateter_Venoso_Central_uma_Reviso_Sistemtica_da_Literatura
23. Manterola C, Asenjo-Lobos C, Otzen T. Jerarquización de la evidencia. Niveles de evidencia y grados de recomendación de uso actual. Rev Chil Infectología [Internet]. Sociedad Chilena de Infectología; 2014;31(6):705–18. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182014000600011&lng=es&nrm=iso&tlng=es
- Resumen visto - 2263 veces
- PDF descargado - 155 veces
